AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2015

Mar 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-03-02

Reporting Person: Higgons John Duncan (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-02	Stock Option (right to buy)	$107.89	A	68000	Acquired	2025-03-01	Common Stock (68000)	Direct

Footnotes

F1: This option was granted on March 2, 2015. The shares underlying this option vest as to 25% of the underlying shares on March 2, 2016, with the remaining 75% vesting in 36 equal monthly installments thereafter.